Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welter

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionationC Pöttgen, W Eberhardt, B Graupner, et al.
Pneumologie (Stuttgart, Germany)|January 21, 2020
[Joint Statement of the German Respiratory Society and German Society of Thoracic Surgery in Cooperation with the German Radiological Society: Structural Prerequisites of Centers for Interventional Treatment of Emphysema]W Gesierich, K Darwiche, F Döllinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic modelS Salah, K Watanabe, S Welter, et al.
European Journal of Neurology|February 14, 2026
Epidemiology and Economic Burden of Sleep Disorders in EuropeClaudio L A Bassetti, Luisa S Welter, Mateo Montes-Martinez, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionationC Pöttgen, W Eberhardt, B Graupner, et al.
Pneumologie (Stuttgart, Germany)|January 21, 2020
[Joint Statement of the German Respiratory Society and German Society of Thoracic Surgery in Cooperation with the German Radiological Society: Structural Prerequisites of Centers for Interventional Treatment of Emphysema]W Gesierich, K Darwiche, F Döllinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic modelS Salah, K Watanabe, S Welter, et al.
European Journal of Neurology|February 14, 2026
Epidemiology and Economic Burden of Sleep Disorders in EuropeClaudio L A Bassetti, Luisa S Welter, Mateo Montes-Martinez, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Pageof 3